Whitehawk Therapeutics Statistics
Total Valuation
WHWK has a market cap or net worth of $183.57 million. The enterprise value is $14.12 million.
| Market Cap | 183.57M |
| Enterprise Value | 14.12M |
Important Dates
The last earnings date was Monday, November 9, 2026, before market open.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
WHWK has 57.01 million shares outstanding. The number of shares has increased by 53.80% in one year.
| Current Share Class | 57.01M |
| Shares Outstanding | 57.01M |
| Shares Change (YoY) | +53.80% |
| Shares Change (QoQ) | +13.25% |
| Owned by Insiders (%) | 8.86% |
| Owned by Institutions (%) | 40.68% |
| Float | 28.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.00 |
| P/TBV Ratio | 1.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.47, with a Debt / Equity ratio of 0.00.
| Current Ratio | 16.47 |
| Quick Ratio | 16.25 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -52.01% and return on invested capital (ROIC) is -34.89%.
| Return on Equity (ROE) | -52.01% |
| Return on Assets (ROA) | -32.82% |
| Return on Invested Capital (ROIC) | -34.89% |
| Return on Capital Employed (ROCE) | -54.80% |
| Weighted Average Cost of Capital (WACC) | 9.55% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.60M |
| Employee Count | 32 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +55.56% in the last 52 weeks. The beta is 0.97, so WHWK's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | +55.56% |
| 50-Day Moving Average | 3.66 |
| 200-Day Moving Average | 3.85 |
| Relative Strength Index (RSI) | 45.97 |
| Average Volume (20 Days) | 400,615 |
Short Selling Information
The latest short interest is 2.62 million, so 4.60% of the outstanding shares have been sold short.
| Short Interest | 2.62M |
| Short Previous Month | 2.71M |
| Short % of Shares Out | 4.60% |
| Short % of Float | 9.12% |
| Short Ratio (days to cover) | 7.25 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -89.46M |
| Pretax Income | -83.29M |
| Net Income | -83.29M |
| EBITDA | -89.46M |
| EBIT | -89.46M |
| Earnings Per Share (EPS) | -$1.06 |
Balance Sheet
The company has $169.67 million in cash and $218,000 in debt, with a net cash position of $169.45 million or $2.97 per share.
| Cash & Cash Equivalents | 169.67M |
| Total Debt | 218,000 |
| Net Cash | 169.45M |
| Net Cash Per Share | $2.97 |
| Equity (Book Value) | 163.16M |
| Book Value Per Share | 1.74 |
| Working Capital | 161.53M |
Cash Flow
In the last 12 months, operating cash flow was -$69.35 million and capital expenditures -$3,000, giving a free cash flow of -$69.35 million.
| Operating Cash Flow | -69.35M |
| Capital Expenditures | -3,000 |
| Depreciation & Amortization | 4,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -69.35M |
| FCF Per Share | -$1.22 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
WHWK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -53.80% |
| Shareholder Yield | -53.80% |
| Earnings Yield | -32.79% |
| FCF Yield | -37.78% |
Analyst Forecast
The average price target for WHWK is $7.71, which is 139.57% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.71 |
| Price Target Difference | 139.57% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
WHWK has an Altman Z-Score of 6.07 and a Piotroski F-Score of 1.
| Altman Z-Score | 6.07 |
| Piotroski F-Score | 1 |